Use of Glucagon-Like Peptide-1 Receptor Agonists in the U.S. Food and Drug Administration’s Sentinel System Read more about Use of Glucagon-Like Peptide-1 Receptor Agonists in the U.S. Food and Drug Administration’s Sentinel System
Strengthening Inferential Studies in the U.S. FDA Sentinel Initiative: Results from a Methodological Demonstration Project Read more about Strengthening Inferential Studies in the U.S. FDA Sentinel Initiative: Results from a Methodological Demonstration Project
Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020 Read more about Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020
Characterization of Dosage of Attention-Deficit/Hyperactivity Disorder (ADHD) Stimulant Medications: A Descriptive Analysis Read more about Characterization of Dosage of Attention-Deficit/Hyperactivity Disorder (ADHD) Stimulant Medications: A Descriptive Analysis
Characterization of Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Medications or Opioid Analgesics: A Descriptive Analysis Read more about Characterization of Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Medications or Opioid Analgesics: A Descriptive Analysis
Self-Reported Use of Non-FDA Approved Cannabinoid Products Among Hospitalized Patients in a Large U.S. Hospital Network Read more about Self-Reported Use of Non-FDA Approved Cannabinoid Products Among Hospitalized Patients in a Large U.S. Hospital Network
Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors, Sodium Glucose Cotransporter 2 Inhibitors, or Sulfonylurea in the U.S. Food and Drug Administration’s Sentinel System Read more about Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors, Sodium Glucose Cotransporter 2 Inhibitors, or Sulfonylurea in the U.S. Food and Drug Administration’s Sentinel System
Risk of Diabetic Ketoacidosis Across Stages of Chronic Kidney Disease in Patients with Type 1 Diabetes in the U.S. Food and Drug Administration’s Sentinel System Read more about Risk of Diabetic Ketoacidosis Across Stages of Chronic Kidney Disease in Patients with Type 1 Diabetes in the U.S. Food and Drug Administration’s Sentinel System
Prevalence of Major Congenital Malformations Among the Insured Population in the United States Using Seven Algorithms Read more about Prevalence of Major Congenital Malformations Among the Insured Population in the United States Using Seven Algorithms
Prevalence of Key Confounding Covariates in a Commercial Electronic Health Records Platform Read more about Prevalence of Key Confounding Covariates in a Commercial Electronic Health Records Platform